Evidence map›Paper›PMID 33198756›Full record

ArticleBMC health services research2020

Shared care follow-up of patients with B-cell neoplasms based on nurse-led telephone consultations and PRO-data: a feasibility study from the North Denmark Region.

Mia Sommer, Lone Frandsen, Paw Jensen, Søren Ramme Nielsen, Lars Børty Nielsen, Rasmus Froberg Brøndum, Martin Bøgsted, Jakob Madsen, Marianne Tang Severinsen, Erik Elgaard Sørensen and 2 more

Abstract read
In one paragraph

Article in BMC health services research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mia SommerDepartment of Hematology, Aalborg University Hospital, Sdr. Skovvej 15, DK-9000, Aalborg, Denmark. m.sommer@rn.dk.ORCID http://orcid.org/0000-0002-9761-6201
Lone FrandsenDepartment of Hematology, Aalborg University Hospital, Sdr. Skovvej 15, DK-9000, Aalborg, Denmark.
Paw JensenDepartment of Hematology, Aalborg University Hospital, Sdr. Skovvej 15, DK-9000, Aalborg, Denmark.
Søren Ramme NielsenDepartment of Hematology, Aalborg University Hospital, Sdr. Skovvej 15, DK-9000, Aalborg, Denmark.
Lars Børty NielsenDepartment of Hematology, Aalborg University Hospital, Sdr. Skovvej 15, DK-9000, Aalborg, Denmark.
Rasmus Froberg BrøndumDepartment of Hematology, Aalborg University Hospital, Sdr. Skovvej 15, DK-9000, Aalborg, Denmark.
Martin BøgstedDepartment of Hematology, Aalborg University Hospital, Sdr. Skovvej 15, DK-9000, Aalborg, Denmark.
Jakob MadsenDepartment of Hematology, Aalborg University Hospital, Sdr. Skovvej 15, DK-9000, Aalborg, Denmark.
Marianne Tang SeverinsenDepartment of Hematology, Aalborg University Hospital, Sdr. Skovvej 15, DK-9000, Aalborg, Denmark.
Erik Elgaard SørensenDepartment of Clinical Medicine, Aalborg University, Aalborg, Denmark.
Mette GrønkjærDepartment of Clinical Medicine, Aalborg University, Aalborg, Denmark.
Tarec Christoffer El-GalalyDepartment of Hematology, Aalborg University Hospital, Sdr. Skovvej 15, DK-9000, Aalborg, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with B-cell neoplasms in remission are monitored with regular physician visits at the hospital. The current standard follow-up procedure is not evidence-based or individualized to patient needs. To improve and individualize the follow-up, we investigated the feasibility of a shared care follow-up initiative, with alternating physician visits and nurse-led telephone consultations and assessments based on patient-reported outcome (PRO) data.

methodsPatients ≥18 years diagnosed with B-cell neoplasms were eligible for the study when they were in remission and stable without treatment for at least 6 months. Patients were assigned to alternating visits with physicians and nurse-led telephone consultations. The nurse-led telephone consultations were based on PROs, which were collected with the European Organization for Research and Treatment of Cancer questionnaire (EORTC-QLQ-C30), the Myeloproliferative Neoplasm - Symptom Assessment Form, and the Hospital Anxiety and Depression Scale. Patients completed questionnaires before every nurse-led consultation. We also applied the Patient Feedback Form to survey patient acceptance of the requirement of questionnaire completion. We applied descriptive statistics, in terms of counts (n) and proportions (%), to describe the study population and all endpoints.

resultsBetween February 2017 and December 2018, 80 patients were enrolled. Adherence, measured as the recruitment rate, was 96% (80/83), and the drop-out rate was 6% (5/80). During the study period, 3/80 (4%) patients relapsed, and 5/80 (6%) patients returned to the standard follow-up, because they required closer medical observation. Relapses were diagnosed based on unscheduled visits requested by patients (n = 2) and patient-reported symptoms reviewed by the nurse (n = 1). The response rate to questionnaires was 98% (335/341). A total of 58/79 (74%) patients completed the Patient Feedback Form; 51/57 (89%) patients reported improved communication with health care professionals; and 50/57 (88%) patients reported improved recollection of symptoms as a result of completing questionnaires.

conclusionBased on patient adherence, a low relapse rate, and positive patient attitudes towards completing questionnaires, we concluded that a shared care follow-up, supported by PROs, was a feasible alternative to the standard follow-up for patients with B-cell disease in remission.

Indexed as

NeoplasmsReferral and ConsultationB-LymphocytesDenmarkFeasibility StudiesFollow-Up StudiesHumansNurse's RolePatient Reported Outcome MeasuresSurveys and QuestionnairesTelephoneFeasibility studyHematologic neoplasmsNurse-led telephone consultationsPatient-reported outcome measuresSupportive care

Identifiers

PMID33198756
PMCPMC7670769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.